Advertisement
Advertisement
RDY
Dr. Reddy's Laboratories Limited - ADR
13.45
USDSponsored
-0.23
-1.69%
Mar 24, 15:59 UTC -4
Closed
Pre-Market
13.53
+0.08
+0.59%
RDY Earnings Reports
Positive Surprise Ratio
RDY beat 23 of 40 last estimates.
57%
Next Report
Date of Next Report
May 07, 2026
Estimate for Q4 26 (Revenue/ EPS)
$87.12B
/$13.36
Implied change from Q3 26 (Revenue/ EPS)
-0.48%
/-7.99%
Implied change from Q4 25 (Revenue/ EPS)
+2.15%
/-30.05%
Dr. Reddy's Laboratories Limited - ADR earnings per share and revenue
On Jan 21, 2026, RDY reported earnings of 14.52 USD per share (EPS) for Q3 26, beating the estimate of 13.86 USD, resulting in a 4.69% surprise. Revenue reached 87.53 billion, compared to an expected 85.48 billion, with a 2.40% difference. The market reacted with a +3.24% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 8 analysts forecast an EPS of 13.36 USD, with revenue projected to reach 87.12 billion USD, implying an decrease of -7.99% EPS, and decrease of -0.48% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Taysha Gene Therapies, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.08
Surprise
+18.45%
Assembly Biosciences, Inc
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.66
Actual
$2.48
Surprise
+474.06%
Sol-Gel Technologies Ltd. Ordinary Shares
Report Date
Mar 23, 2026 For Q4 25
Estimate
$0.39
Actual
-Surprise
-
FAQ
What were Dr. Reddy's Laboratories Limited - ADR's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Dr. Reddy's Laboratories Limited - ADR reported EPS of $14.52, beating estimates by 4.69%, and revenue of $87.53B, 2.4% above expectations.
How did the market react to Dr. Reddy's Laboratories Limited - ADR's Q3 2026 earnings?
The stock price moved up 3.24%, changed from $13.28 before the earnings release to $13.71 the day after.
When is Dr. Reddy's Laboratories Limited - ADR expected to report next?
The next earning report is scheduled for May 07, 2026.
What are the forecasts for Dr. Reddy's Laboratories Limited - ADR's next earnings report?
Based on 8
analysts, Dr. Reddy's Laboratories Limited - ADR is expected to report EPS of $13.36 and revenue of $87.12B for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement